SCHEMBL6259635

SCHEMBL6259635

OCCn1cnc2cncnc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.55
ADORA2A P29274 3/20 0.50
ADORA1 P30542 2/20 0.50
LTA4H P09960 1/20 0.50
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
CYP1A2 P05177 5/20 0.40
LMNA P02545 3/20 0.37
ADORA2B P29275 2/20 0.37
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP2C9 P11712 2/20 0.35
USP2 O75604 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 1/20 0.35
TSHR P16473 2/20 0.35
MEN1 O00255 1/20 0.35
HBB P68871 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30166038 1.00 FDPS (0.55) FDPSADORA2AADORA1LTA4HHDAC1
Water SCHEMBL27592739 0.98 FDPS (0.54) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL8464130 0.87 FDPS (0.50) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL9936014 0.85 FDPS (0.62) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL364678 0.82 FDPS (0.56) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL4020843 0.82 FDPS (0.51) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL3671306 0.82 FDPS (0.51) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL31024294 0.82 FDPS (0.51) FDPSADORA2AADORA1LTA4HHDAC1
SCHEMBL9597540 0.82 FDPS (0.55) FDPSLTA4HHDAC1HDAC6CYP1A2
SCHEMBL5017277 0.82 FDPS (0.51) FDPSADORA2AADORA1LTA4HHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101544641-A Novel anticancer-active purine nucleoside compounds modified by monoazacrown ether at 6-position and preparation method thereof UNIV HENAN NORMAL 2009-09-30 CN claimed
WO-2023086970-A2 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACIDS AND NUCLEASES IN A BODY FLUID AS INDICATORS OF DISEASE ARNA GENOMICS US INCORPORATED (US) 2023-05-19 WO disclosed
CN-115677807-A 6-position alpha-hydroxyalkylated purine compounds and methods for modification thereof 鲁东大学 2023-02-03 CN disclosed
CN-115583950-A Method for modifying purine Compounds and 6-position acylpurine Compounds 鲁东大学 2023-01-10 CN disclosed
CN-101544641-B Novel anticancer-active purine nucleoside compounds modified by monoazacrown ether at 6-position and preparation method thereof UNIV HENAN NORMAL 2010-12-08 CN disclosed
CN-101544641-A Novel anticancer-active purine nucleoside compounds modified by monoazacrown ether at 6-position and preparation method thereof UNIV HENAN NORMAL 2009-09-30 CN disclosed
CN-101492449-A 6-N,N-dihydroxyethyl purine new compounds with anticancer activity and preparation method thereof UNIV HENAN NORMAL (CN) 2009-07-29 CN disclosed
CN-100455583-C 2-amino-9- (2-substituted ethyl) purines and methods of using same to prepare 9- [ 4-acetoxy-3- (acetoxymethyl) butan-1-yl ] -2-aminopurine KYUNGDONG PHARM CO LTD (KR) 2009-01-28 CN disclosed
CN-1791602-A 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same KYUNGDONG PHARM CO LTD (KR) 2006-06-21 CN disclosed
CN-1234718-C New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2006-01-04 CN disclosed
WO-2005065668-A2 TOPICAL COMPOSITIONS COMPRISING HALO-DEOXYADENOSINES FOR TREATMENT OF SKIN DISORDERS QLT USA, INC. (US) 2005-07-21 WO disclosed
CN-1464880-A New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2003-12-31 CN disclosed
EP-1349857-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2003-10-08 EP disclosed
EP-1313751-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY Basilea Pharmaceutica AG (CH) 2003-05-28 EP disclosed
WO-2002055521-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2002-07-18 WO disclosed
WO-2002016380-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY BASILEA PHARMACEUTICA AG (CH) 2002-02-28 WO disclosed
US-5270322-A Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them DR. KARL THOMAE GMBH (DE) 1993-12-14 US disclosed